JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
PVCT Financials - Provectus Biopharmaceuticals Income & Cash Flow | Ledgeburg
PVCT - Provectus Biopharmaceuticals, Inc.
USD | OTC Markets | Healthcare
Summary
Summary PVCT Stock
Financials
Financials PVCT Stock
Loading...
Loading...
Income Statement
Income Statement PVCT Stock
Balance Sheet
Balance Sheet PVCT Stock
Cash Flow Statement
Cash Flow Statement PVCT Stock
Loading...
Loading...
Home
Stocks
Provectus Biopharmaceuticals, Inc. (PVCT)
Financials
Financials of PVCT
Loading...
Loading...
Loading...
Loading...
Revenue
$336.108K
Operating Income
$-5.294765M
Net Income
$-5.505124M
Share Count (Basic)
420.279879M
Operating Cash Flow
$-3.325991M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$251.291K
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
200K
400K
600K
800K
1M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50K
100K
150K
200K
250K
Q1 FY25
Q2 FY25
Annual
Quarterly
Net Income $USD
-5.5M
-5M
-4.5M
-4M
-3.5M
-3M
Annual
Quarterly
Margins
Gross
Operating
Net
-1500%
-1000%
-500%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-1.8M
-1.6M
-1.4M
-1.2M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-3000%
-2000%
-1000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26